Bitcoin ETFs See $336M Inflows; Ether Posts 10th Day
Bitcoin ETFs recorded $336 million in net inflows on April 22, led by BlackRock’s IBIT. Ether ETFs added $96.4 million, registering a 10th consecutive day of inflows.
On April 22, bitcoin exchange-traded funds recorded $335.8 million in net inflows, while ether ETFs added $96.4 million. Bitcoin funds posted a seventh straight day of net inflows, totaling about $1.87 billion over that period.
BlackRock’s IBIT led bitcoin flows with $246.9 million. Fidelity’s FBTC took in $56.7 million, Bitwise’s BITB added $15.4 million, and Ark & 21Shares’ ARKB received $11.9 million. Morgan Stanley’s MSBT added $11.3 million, WisdomTree’s BTCW added $6.26 million, and Vaneck’s HODL added $3.9 million. Grayscale’s GBTC had $16.6 million in outflows. Trading volume for bitcoin ETFs was $3.03 billion and total net assets across the segment rose to $100.98 billion.
Ether ETFs saw concentrated inflows. BlackRock’s ETHA drew $53.6 million and Fidelity’s FETH brought in $40.62 million. Grayscale’s Ether Mini Trust added $11.37 million, while Grayscale’s larger ETHE experienced $9.2 million in redemptions. Trading volume across ether ETFs was $813.35 million and combined net assets reached $13.94 billion.
Smaller token products showed mixed activity. XRP ETFs recorded $2.42 million in net inflows, with trading volume of $11.07 million and total net assets of $1.09 billion. Solana ETFs reported no trading activity for a second consecutive session, and their net assets remained at $887.92 million.
Trading volumes were elevated for major ETF groups and total bitcoin ETF assets returned above the $100 billion mark on April 22.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.






